Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

We characterized health-related quality of life (HRQoL), cognitive, and functional status in newly diagnosed glioblastoma (GBM) patients receiving Tumor treating fields (TTFields) with temozolomide (TMZ) versus TMZ alone in a planned interim analysis of a randomized phase III trial [NCT00916409], wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jay-Jiguang, Demireva, Petya, Kanner, Andrew A., Pannullo, Susan, Mehdorn, Maximilian, Avgeropoulos, Nicholas, Salmaggi, Andrea, Silvani, Antonio, Goldlust, Samuel, David, Carlos, Benouaich-Amiel, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700237/
https://www.ncbi.nlm.nih.gov/pubmed/28849310
http://dx.doi.org/10.1007/s11060-017-2601-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700237/
https://www.ncbi.nlm.nih.gov/pubmed/28849310
http://dx.doi.org/10.1007/s11060-017-2601-y

Ejemplares similares